Artiva Total Assets from 2010 to 2024
| ARTV Stock | 10.40 0.22 2.07% |
Total Assets | First Reported 2010-12-31 | Previous Quarter 105.1 M | Current Value 120.3 M | Quarterly Volatility 48.8 M |
Check Artiva Biotherapeutics, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Artiva Biotherapeutics,'s main balance sheet or income statement drivers, such as Net Interest Income of 2.7 M, Interest Income of 2.7 M or Depreciation And Amortization of 2.4 M, as well as many indicators such as Price To Sales Ratio of 3.18, Dividend Yield of 0.0 or Days Sales Outstanding of 18.2. Artiva financial statements analysis is a perfect complement when working with Artiva Biotherapeutics, Valuation or Volatility modules.
Artiva | Total Assets |
Latest Artiva Biotherapeutics,'s Total Assets Growth Pattern
Below is the plot of the Total Assets of Artiva Biotherapeutics, Common over the last few years. Total assets refers to the total amount of Artiva Biotherapeutics, assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Artiva Biotherapeutics, books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Artiva Biotherapeutics,'s Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Artiva Biotherapeutics,'s overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 105.11 M | 10 Years Trend |
|
Total Assets |
| Timeline |
Artiva Total Assets Regression Statistics
| Arithmetic Mean | 56,662,213 | |
| Geometric Mean | 43,523,512 | |
| Coefficient Of Variation | 86.11 | |
| Mean Deviation | 40,228,046 | |
| Median | 29,234,000 | |
| Standard Deviation | 48,794,527 | |
| Sample Variance | 2380.9T | |
| Range | 140.7M | |
| R-Value | 0.71 | |
| Mean Square Error | 1265.2T | |
| R-Squared | 0.51 | |
| Significance | 0 | |
| Slope | 7,765,594 | |
| Total Sum of Squares | 33332.7T |
Artiva Total Assets History
Other Fundumenentals of Artiva Biotherapeutics,
Artiva Biotherapeutics, Total Assets component correlations
Click cells to compare fundamentals
About Artiva Biotherapeutics, Financial Statements
Artiva Biotherapeutics, investors use historical fundamental indicators, such as Artiva Biotherapeutics,'s Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Artiva Biotherapeutics,. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Assets | 105.1 M | 120.3 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Artiva Stock Analysis
When running Artiva Biotherapeutics,'s price analysis, check to measure Artiva Biotherapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artiva Biotherapeutics, is operating at the current time. Most of Artiva Biotherapeutics,'s value examination focuses on studying past and present price action to predict the probability of Artiva Biotherapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artiva Biotherapeutics,'s price. Additionally, you may evaluate how the addition of Artiva Biotherapeutics, to your portfolios can decrease your overall portfolio volatility.